Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

Ophthalmologists use optical coherence tomography (OCT) to assess whether a patient with age-related macular degeneration (AMD) requires treatment at their scheduled appointment or can wait a few more ...

Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio.

Sponsored content Eye health is something many of us take for granted. But looking after our eyes is important for ...

MEDIA RELEASEAfqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One ...

Sandoz (SDZNY) said that the European Commission has granted marketing authorization for Afqlir (aflibercept) 2 mg vial kit and ...

HealthDay News — Socioeconomic factors are linked to an increased risk for age-related macular degeneration (AMD), according to a study published online July 1 in Health Data Science.

SUMMARY: Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology ...

Neuralink Corp., Elon Musk’s brain-computer venture, and rivals like Science Corp. are making strides in technology that ...

The Healthcare Private Equity team has advised Retina Consultants of America (RCA) and Webster Equity Partners in the sale of ...

Researchers at Johns Hopkins University have identified a process in the eye that may explain why biologic drugs for treating ...